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Abstract

Background: Unintended pregnancy disproportionately affects younger, minority, and low-income women. The
purpose of this analysis is to describe our recruitment strategies and to determine if targeted efforts to reach
women at greatest risk for unintended pregnancy and sexually transmitted infection (STI) were successful.
Methods: The Contraceptive CHOICE Project is a prospective cohort study providing reversible contraception at
no cost to 10,000 women aged 14–45 years in the St. Louis area in order to evaluate method satisfaction and
continuation and to reduce unintended pregnancies in the region. We describe four strategies for effective
outreach and recruitment of high-risk women, including forming strong community partnerships. We analyze
the evolution of baseline demographic and behavioral characteristics over the three waves of enrollment of the
first 2,500 participants in order to assess whether our outreach efforts were successful.
Results: Overall, >60% of participants were aged 25 years. There was a significant increase in the percentage of
minority participants enrolled throughout the first 2,500 subjects ( p < 0.001). The number of women who reported trouble paying for basic necessities significantly increased over the three waves ( p ¼ 0.025). Throughout
the three waves of enrollment, there was a significant increase in the number of women who tested positive for
an STI at baseline ( p < 0.001).
Conclusions: A multiple method approach with collaboration of key community partners led to successful
recruitment of hard to reach populations at high risk for unintended pregnancy and STI.

Introduction

A

ll women should have the opportunity to make
decisions about their own reproductive health and if and
when they desire pregnancy. Of the 6.4 million pregnancies
that occur in the United States each year, however, nearly half
(49%) are unintended.1 Unintended pregnancy in the United
States affects certain subgroups of the population at much
higher rates; these groups include young women (aged 18–25
years), those with lower-income status and lower education
level (did not complete high school), and minority race.1–4
In nearly half (48%) of all unintended pregnancies, contraceptives were used during the month of conception.1
Contraceptive failure is most often a result of inconsistent or
incorrect use.5 Women of low income, minority racial or
ethnic groups, or younger age are more likely to experience
elevated contraceptive failure rates.3 Long-acting reversible

methods of contraception (LARC), which include intrauterine
devices (IUDs) and the subdermal implant, have been proven
to be the most effective methods of reversible contraception, with failure rates of <1% in the first year of use.6 These
methods do not require routine compliance, such as daily or
weekly regimens. There is no significant difference in the effectiveness of the long-acting methods across racial or ethnic
groups.3
Despite their known safety and effectiveness, LARC use is
much lower in the United States compared with the rest of the
world.7 One reason for this is that misconceptions and myths
about IUDs remain among women and healthcare providers;
as a result, they are often not offered to women as first-line
options or to women who are at higher risk for infection and
unintended pregnancy.8–10 LARC methods are also associated
with a higher upfront cost to both patient and provider despite their cost-effectiveness in the long term.11

Washington University in St. Louis School of Medicine, Division of Clinical Research, Department of Obstetrics and Gynecology, St. Louis,
Missouri.

2233

2234
Previous studies have reported the challenges that occur
when identifying, enrolling, and retaining high-risk or hardto-reach populations in research. These challenges include a
generalized distrust among minorities of medical research, a
lack of clinical trials at facilities where minorities seek medical
care, ineffective communication by research staff, complicated record-keeping requirements, a lack of incentives, and
lack of transportation or child care.12 The reasons cited more
often by minority subjects who withdrew from a multicenter
research trial were lack of time, negative side effects, and
dissatisfaction with the overall research process.12,13
The Contraceptive CHOICE Project (CHOICE) was developed to (1) increase awareness and acceptance of LARC, (2)
remove the knowledge and financial barriers to the most
effective methods of birth control, and (3) decrease the rate of
unintended pregnancy at the population level among women
in the St. Louis area. During the development phase of the
study, we identified and implemented specific recruitment
strategies to increase enrollment among women at highest
risk for unintended pregnancy and sexually transmitted infection (STI). This report describes the evolution of demographic and behavioral characteristics of the first 2,500
women enrolled in CHOICE during a 17-month enrollment
period. Our objective is to demonstrate that the expanded
efforts to reach high-risk women were successful in improving recruitment and enrollment of these women into the
study.
Materials and Methods
The Contraceptive CHOICE Project (CHOICE) methods
have been described previously.14 In summary, CHOICE is a
prospective cohort study planning to enroll 10,000 women
aged 14–45 years in the St. Louis area. Eligible women have
been sexually active with a male partner in the past 6 months
or anticipate sexual activity in the next 6 months, have not had
a tubal ligation or hysterectomy, do not desire pregnancy in
the next year, and are interested in starting a new reversible contraceptive method. Each participant is provided
reversible contraceptive method(s) of her choice at no cost for 3
years. At enrollment, each participant receives contraceptive
counseling, STI (Chlamydia trachomatis, Neisseria gonorrhoeae,
Trichomonas vaginalis, syphilis, and HIV) screening, and a staffadministered standardized survey instrument. After her inperson baseline enrollment session, the participant is interviewed by telephone seven times (3 months, 6 months, and
every 6 months to 3 years) to measure method continuation, satisfaction, and pregnancy occurrence. The Washington
University in St. Louis Human Research Protection Office approved the protocol before participant recruitment.
During the development phase of the study, we identified
four strategies to ensure the successful recruitment of highrisk women, as identified by age 25, minority racial or ethnic
group, low income, and a history of or current STI (Table 1).
First, we identified community partners that shared similar
goals and objectives. The community partners included federally qualified health centers, local family planning clinics,
and clinics providing abortion services. We identified areas of
our metropolitan area with high STI prevalence and targeted
clinics in those neighborhoods as well as clinics in any location providing abortion services. Once a community site was
willing to partner with us, we confirmed that the clinic serves
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our target population by requesting data on the range of patient age, race, income, and the clinic’s service region.
We established mutually beneficial relationships for both
the community sites and CHOICE to ensure the sustainability
of the relationship over time. CHOICE and the community
partners shared organizational priorities to identify recruitment challenges, competing needs, and financial considerations and possible solutions. For example, together we
recognized the importance for research staff to recruit at
community clinics to reach women who did not or would not
seek care at a university-affiliated clinic; in turn, we acknowledged the value of ensuring that study participants
continued to receive medical services within the community
partner clinics. Similarly, by establishing a trusted relationship with community-based partners, the study referred
women recruited at the university-affiliated clinic to the
community clinics for future medical services. Through this
mutually supportive system, we were able to recruit the target
population from sites where women actually seek reproductive health services and ensure that we promoted continued
care within the community clinics. Staff at the community
clinics became our biggest proponent and promoted the study
to their patient population.
Second, we recognized our inability to recruit at all area
clinics and reproductive health providers because of staffing
limitations. In response, we initiated conversations with private providers who expressed an interest in the study and
encouraged referral of their patients to the study to obtain
contraception. We provided posters and pamphlets to have on
display and available in their clinics. We again established a
system wherein private patients were referred to CHOICE for
enrollment and referred back to the private physician for
clinical care, contraceptive method insertion (if applicable),
and management. We believed that a referral by a trusted
medical provider would provide the patient with an important
level of confidence and legitimacy so that she would contact
the study for more information and subsequent participation.
Third, we established a standardized recruitment monitoring process to regularly evaluate recruitment goals and
outcomes. To meet our target of 10,000 women enrolled in 4
years, our enrollment goal was approximately 200 women
each month. For each recruitment location, we generated a
database that was updated daily to enumerate the number of
women approached and the number of women who enrolled
by age and race. We also reported reasons for ineligibility and
reasons for not enrolling in the study. We documented recruitment days, time spent during each recruitment event,
and unusual circumstances that may have influenced recruitment. Initially, we monitored recruitment outcomes on a
daily basis to identify successes, challenges, and new recruitment strategies. Over time, we transitioned to monitoring
recruitment goals and outcomes on a weekly basis to account
for daily fluctuations.
Finally, we did not underestimate the magnitude of a
positive participant experience and the value of word-ofmouth advertising. The research staff was trained and repeatedly reminded to prioritize each woman’s experience to
ensure her level of comfort, her questions were answered, her
confidentiality was protected, and our appreciation of her
participation was verbalized. During the course of the enrollment session, we offer participants small cards with
CHOICE contact information to pass along to friends or
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Table 1. Recruitment Strategies Used to Enroll Women at Risk of Unintended Pregnancy
into Contraceptive CHOICE Project
Form mutually beneficial relationships with community
partners serving target population
Identify community partners
Federally qualified health centers
(Title X) family planning clinics
Located in high-prevalence STI areas
Provide abortion services
Confirm sites serve target population
through existing data sources
Identify organizational strengths and weaknesses
Priorities
Challenges
Financial constraints
Referral location for women who don’t have
a current provider
Develop and formalize mutually agreed
upon protocols and remuneration

Expand beyond designated recruitment sites
Identify private providers willing to refer
their patients to CHOICE
Demonstrate willingness to refer patient back
to provider for method insertion to ensure
continuity of care
Consistently provide study pamphlets and posters
to private provider network
Refer patients back to private providers for ongoing
management

Standardize recruitment monitoring process
to evaluate recruitment outcomes
Establish recruitment goals
Weekly to account for daily fluctuations
Create database to collect key recruitment indices
Age
Race
Recruitment location
Recruitment time
Reasons for ineligibility
Reasons for not enrolling
Review recruitment indices on a regular basis to identify
Successes
Challenges
New strategies
Implement and monitor new strategies

Create a positive experience for each participant
and facilitate additional enrollments within
her social network
Ensure staff is trained to provide positive experience
Prioritize each participant’s CHOICE interaction
Ensure she is comfortable
Encourage and answer her questions
Demonstrate that we will protect her confidentiality
Thank her for her participation
Distribute Project contact information cards to
participants to give to her friends and family
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&

&

&

&

&
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STI, sexually transmitted infection.

family members who might be interested in CHOICE. This
strategy was implemented to encourage women who are
trusted by friends or family members to speak positively
about their CHOICE experience and possibly facilitate additional enrollments within their peer or social networks.
In this report, we analyze the effectiveness of our recruitment strategies and whether we have successfully recruited
women at high risk for unintended pregnancy and STI
over time. We compare demographic and behavioral characteristics among the first three waves of women enrolled in
CHOICE. Specifically, of the first 2,500 women enrolled,
we compared waves of 500, 1,000, and 1,000 women enrolled.
We examine several risk factors for unintended pregnancy
including age, race, financial status, and STI at the time of
enrollment. Statistical analyses were conducted using SAS
Software (version 9.1., SAS Institute, Cary, NC). The chi-square
test was used for categorical variables, and a t test or analysis of
variance (ANOVA) was used for continuous variables.
Results
The first 2,500 subjects of CHOICE were enrolled over a 17month period, from August 2007 to December 2008. During
that time, 4,197 women were screened and 3,524 (84%) were
eligible. The first 500 women (wave 1) were enrolled in months
1–6 of the study; these participants were recruited at the

university-affiliated clinic and one clinic providing abortion
services. Participants 501–1,500 (wave 2) were enrolled in
months 7–12; one clinic providing abortion services and two
family planning clinics were added as recruitment sites during
this wave. Participants 1,501–2,500 (wave 3) were enrolled in
months 13–17, and four additional family planning clinics as
well as one no-cost teen clinic were added as recruitment sites.
Overall, 26% of the participants were recruited at a community-based partner clinic: 18% at the abortion facilities and 8%
at the federally qualified health centers or family planning
clinics (Table 2). There was not a significant increase in recruitment at community-based clinics between waves 1 and 2
( p ¼ 0.315). However, when numerous additional community
clinics were added in wave 3, there was a significant increase
between waves 2 and 3 in the number of participants enrolled
outside of the university-affiliated clinic ( p < 0.001).
We observed changes in the demographic and economic
profiles among the three comparison groups. The number of
participants who identified themselves as black significantly
increased early in the study, from 33% in wave 1 to 47% in
wave 2 ( p < 0.001). This early increase in minority race was
stable between waves 2 and 3 ( p ¼ 0.928). The age of the
participants remained consistent over time. The average age
of participants was 25 years, ranging from 14 to 45 years.
Overall, >60% of participants were aged 25, and 99 participants (6%) were minors <18 years (Table 2).
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Table 2. Evolution of Demographic and Behavioral Characteristics
Throughout First Three Waves of Enrollment in Contraceptive CHOICE Project, n ¼ 2,500
Total

Recruitment clinic
University-affilliated
Abortion
Family planning=community
health
Race
Black
White
Other
Hispanic
Yes
Age
<18
18–20
21–25
>25
Trouble paying
Yes
Receive public assistance
Yes
Trouble paying or receiving
assistance
Yes
Lifetime sex partners
0–1
2–4
5–9
10þ
History of abortion
Yes
Any STI diagnosis in lifetimea
Yes
Any STI at baselineb
Yes
Parity
0
1
2
3þ
Reached desired parity
Yes

n

%

Wave 1
1st 500
%

Wave 2
2nd 1000
%

Wave 3
3rd 1000
%

1845
444
211

73.8
17.8
8.4

78.6
17.0
4.4

75.1
19.5
5.4

70.1
16.4
13.5

1086
1209
190

43.7
48.7
7.6

32.5
60.6
6.9

46.7
45.6
7.6

46.2
45.7
8.1

114

4.6

3.6

4.4

5.2

99
426
1053
922

4.0
17.0
42.1
36.9

3.8
15.8
44.6
35.8

3.5
18.0
41.6
36.9

4.5
16.7
41.4
37.4

968

39.0

36.7

36.9

42.3

719

28.9

25.5

29.5

29.9

1281

51.7

47.8

50.9

54.4

364
671
849
616

14.6
26.8
34.0
24.6

13.8
28.6
30.0
27.6

14.0
26.1
36.3
23.6

15.5
26.7
33.6
24.2

1128

45.1

48.0

48.1

40.7

702

28.4

26.4

27.2

30.6

120

4.8

2.4

4.0

6.8

1236
585
429
250

49.4
23.4
17.2
10.0

50.4
24.6
16.0
9.0

48.5
23.0
18.5
10.0

49.9
23.2
16.4
10.5

953

38.1

39.0

38.0

37.8

p value

Wave
1 vs. 2
p value

Wave
2 vs. 3
p value

Wave
1 vs. 3
p value

<0.001

0.315

<0.001

<0.001

<0.001

<0.001

0.928

<0.001

0.360

0.461

0.408

0.167

0.742

0.608

0.620

0.663

0.025

0.949

0.014

0.040

0.167

0.104

0.811

0.069

0.046

0.254

0.121

0.016

0.233

0.079

0.583

0.268

0.001

0.971

0.001

0.007

0.144

0.733

0.104

0.097

<0.001

0.110

0.006

<0.001

0.779

0.546

0.661

0.783

0.899

0.707

0.927

0.652

a

Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, syphilis, herpes, or HIV.
Chlamydia trachomatis, Neisseria gonorhoeae, Trichomonas vaginalis.

b

The number of participants who reported they had trouble
paying for transportation, housing, medical expenses, or food in
the past 12 months increased significantly from 37% in wave 2 to
42% in wave 3 ( p ¼ 0.014). The number of women currently
receiving food stamps, Women, Infants, and Children (WIC),
welfare, or unemployment benefits also increased over time,
although not significantly from wave 1 to wave 3 ( p ¼ 0.069).
Combined, the number of participants who reported difficulty
paying for basic necessities or currently receiving public assistance increased from 48% in wave 1 to 54% in wave 3 ( p ¼ 0.016).
The number of reported lifetime sexual partners remained
consistent across the three waves in the first 2,500 participants.
Overall, 59% of participants reported 5 lifetime sexual partners. Forty-five percent of participants reported a history of
abortion. The proportion of participants with a self-reported

history of STI diagnosis (including C. trachomatis, N. gonorrhoeae, T. vaginalis, syphilis, herpes, or HIV) was 28% (Table 2).
Although we did not observe a significant increase in selfreported history of STI over time, we did observe a statistically
significant increase in the number of participants who tested
positive for an STI (C. trachomatis, N. gonorrhoeae, or T. vaginalis) at their baseline enrollment session, from 2% in wave 1
to 7% in wave 3 ( p < 0.001). There is no difference among
the waves in terms of parity or the number of participants
who have already reached their desired parity (Table 2).
Discussion
Significant disparities exist in the sexual and reproductive
health of women in the United States. CHOICE has focused its
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recruitment efforts to increase participation among women at
high risk of unintended pregnancy, including women of
low income, younger age, black race, and those who engage
in high-risk sexual behaviors.2–5,15 We believe our efforts to
reach high-risk women have been successful. Our success has
been accomplished through expansion of recruitment sites
to include community health and family planning clinics located throughout the recruitment catchment area, especially
in low-income neighborhoods. CHOICE has forged strong
relationships with healthcare providers and staff at the community-based clinics, who play an important role in introducing CHOICE to their patient population. Furthermore,
existing participants through word-of-mouth referred other
women to CHOICE. Planned efforts to further increase
awareness of the project include advertisements in city
newspapers and on local radio stations as well as on public
transportation buses and trains.
During the first 17 months of recruitment, the demographic
and sexual risk characteristics of the participants changed over
time. The number of black participants significantly increased,
and nearly half of our participants are from a minority racial or
ethnic group. The large proportion of minority women enrolled in CHOICE accurately reflects the racial distribution of
the recruitment catchment area of St. Louis city, where 49% of
the residents are black, 47% are white, and 3% are of Hispanic
ethnicity.16 We also observed a significant increase in the
number of participants reporting difficulty paying for basic
necessities or receiving public assistance. Finally, the number
of participants who tested positive for an STI at baseline enrollment significantly increased over time. These three indicators of high risk suggest that one or more of the four strategies
implemented to reach high-risk women has been effective
in recruiting our target population. However, because the recruitment strategies were not staged but implemented in
overlapping time intervals early in the study, the effectiveness
of each strategy cannot be evaluated individually.
Although we enrolled 99 women <18 years of age, we did
not observe a significant increase in the number of teen participants during this time period, suggesting that our strategies were not focused on the youngest women at risk of
pregnancy. This may be because parental consent is required
for minor participation in the study. Alternatively, teens may
not seek care at the community clinics where we offer participation. We initiated recruitment at a teen clinic that provides no-cost healthcare services in the last month of the third
wave and expect to see increased enrollment from that site in
future recruitment waves. Because adolescents are a target
population for the study, measures have been undertaken to
identify additional teen-specific clinics in the community.
The disparities seen in rates of unintended pregnancy are
mirrored in rates of abortion. More than half (56%) of women
obtaining an abortion are in their 20s, and women aged 20–24
have a higher abortion rate than any other age group. Women
with incomes below 200% of poverty comprise 30% of all
women of reproductive age but accounted for 57% of all
women having abortions in 2000. Additionally, the abortion
rate in white women (13=1,000) is the lowest of any racial
group, but that of black women (49=1,000) is the highest.2
CHOICE’s partnership with clinics providing abortion services provides women with an opportunity for contraception
who may not otherwise seek or have access to routine reproductive healthcare or affordable contraception at the time
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of an abortion procedure. Furthermore, participants are able
to obtain their chosen method immediately at the time of their
procedure, thus eliminating the need to return at a later date
to obtain contraception.
Substantial health disparities also exist in the rates of STI in
the United States; the rate of infection with N. gonorrhoeae is 19
times higher in black women than white women, and the rate of
infection with C. trachomatis is more than 8 times higher in black
women than white women.17,18 Young age is also a risk factor
for STI, with the highest rates in 15–19 and 20–24 year olds.18,19
Additional STI risk factors include low socioeconomic status,
limited access to healthcare, incarceration, and involvement in
highly infected sexual networks.20–22 Within this analysis, we
are able to demonstrate that efforts to enroll women at risk of
unintended pregnancy also effectively enrolled women at high
risk of STI, as shown by increased rates of STI at the time of
enrollment. Health disparities occur in behaviors that overlap,
including STI and unintended pregnancy, and should be considered in tandem within high-risk populations.23
Women of low income, those of minority racial or ethnic
groups, and younger women are more likely to experience
elevated contraceptive failure rates.3,5 The average failure rate
across all contraceptive methods as a group in the first year of
use is >10% for all women except those aged 30–44, married,
or in the highest income status category. In the second year of
method use, the failure rate remains >10% only for women
with an income less than 250% of poverty and black women.3
These disparities in failure rates likely exist for several reasons. Contraceptive users in these groups may have less
education about consistent and correct method use. Additionally, these women have limited access to the resources
to obtain contraceptives routinely and at an affordable price.3
In order to lessen these disparities, CHOICE is removing
financial barriers, providing straightforward access to all
contraceptive methods, including refillable methods, and
providing education on proper method use.
Given that contraceptive failure is more likely with the refillable methods, a forgettable method that is not user dependent and does not need to be obtained on a routine basis is
preferable. For this reason, CHOICE provides a brief educational message on the safety and effectiveness of long-acting
reversible methods to all participants. The goal is to dispel
widespread myths and misinformation about LARC.24,25 The
long-acting reversible methods may be even more preferable
for those high-risk women with limited access to contraception, an unstable income, or a lack of knowledge on appropriate method use.
Conclusions
The Contraceptive CHOICE Project aims to have a population-level impact on the rate of unintended pregnancy in the
St. Louis area by providing reversible contraception of the
woman’s choice at no cost. In order to truly reduce unintended pregnancy at a population level, the project must
reach the women at highest risk for unintended pregnancy
and provide the most effective methods of contraception. We
believe that through a multiple method approach, with collaboration of key community partners, we have been increasingly effective at reaching high-risk women during the
time period wherein the first 2,500 participants enrolled in
the study. Future efforts will identify additional strategies to
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increase recruitment of teens and to maintain our recruitment
of minority and lower-income women.
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